Journal article
Do nonglycaemic effects such as weight loss account for HbA1c lowering with efpeglenatide?: Insights from the AMPLITUDE‐O trial
Authors
Gerstein HC; Yang M; Lee SF; Branch KRH; Del Prato S; Lam CSP; Lopes RD; Pratley R; Rosenstock J; Sattar N
Journal
Diabetes Obesity and Metabolism, Vol. 26, No. 12, pp. 6080–6084
Publisher
Wiley
Publication Date
December 1, 2024
DOI
10.1111/dom.15957
ISSN
1462-8902